Micropaque (Barium Sulfate)

Barium sulfate, the active ingredient in Micropaque, is a contrast media presented as a suspension for oral and rectal use. It provides radiopaque contrast that enhances visualization of the gastrointestinal tract during diagnostic imaging procedures, helping clinicians assess anatomy and pathology in patients undergoing gastrointestinal studies. GNH USA supplies Micropaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Micropaque is a radiographic contrast agent used to improve imaging of the gastrointestinal tract. - Upper gastrointestinal tract imaging (barium swallow): enables clear visualization of the esophagus, stomach and duodenum for diagnostic assessment. - Lower gastrointestinal tract imaging (barium enema): provides detailed images of the colon and rectum to detect lesions, strictures or inflammatory changes. - Contrast studies of the gastrointestinal tract: supplies a uniform radiopaque medium that outlines the entire GI lumen for comprehensive radiographic evaluation.

Micropaque may cause mild, transient reactions in some patients.

Common Side Effects: - Nausea: mild discomfort that usually resolves after the procedure. - Vomiting: occasional expulsion of the suspension. - Abdominal discomfort: cramping or bloating during or after administration. - Constipation: temporary reduced bowel movements. - Mild diarrhea: brief loose stools. - Skin rash: limited erythema at the site of contact.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Aspiration: inhalation of the suspension leading to respiratory compromise. - Gastrointestinal perforation: risk if the bowel wall is already compromised. - Severe abdominal pain: persistent intense pain indicating possible complication. - Electrolyte imbalance: rare disturbance due to fluid shifts. - Severe dehydration: significant fluid loss requiring rehydration.

Before using Micropaque, clinicians should consider several safety measures. - Assess for bowel obstruction: avoid administration if obstruction is suspected. - Evaluate recent gastrointestinal surgery: contraindicated in patients with recent operative sites. - Check for known hypersensitivity to barium sulfate: do not use in allergic individuals. - Ensure adequate hydration: advise patients to drink fluids post‑procedure to facilitate clearance. - Use caution in pregnancy: category B, weigh diagnostic benefit against potential fetal exposure. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Micropaque can interact with other agents that affect gastrointestinal function or imaging quality.

Major Interactions (Avoid): - Concurrent oral iron supplements: may cause precipitation and reduce image clarity. - Other oral contrast agents (iodinated): can lead to additive GI irritation. - Strong laxatives taken immediately before the study: may interfere with coating of the mucosa.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may alter suspension consistency. - Proton pump inhibitors: can modify gastric pH and affect imaging contrast. - Opioid analgesics: may increase risk of constipation and discomfort during the procedure.